BioSig Technologies Inc
BSGM6.100USD
0.000
Close 12/22, 16:00（ET）Quotes delayed by 15 min
187.84MMarket Cap
LossP/E TTM
More Details of BioSig Technologies Inc Company
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is designed to pinpoint even the complex signals to maximize procedural success and efficiency. The PURE EP System is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time.
BioSig Technologies Inc Info
Ticker SymbolBSGM
Company nameBioSig Technologies Inc
IPO dateSep 22, 2014
CEOMr. Henry Mcphie
Number of employees5
Security typeOrdinary Share
Fiscal year-endSep 22
Address55 Greens Farms Road
CityWESTPORT
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code06880
Phone12034095444
Websitehttps://www.biosig.com/
Ticker SymbolBSGM
IPO dateSep 22, 2014
CEOMr. Henry Mcphie
Company Executives of BioSig Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Ferdinand Groenewald
Mr. Ferdinand Groenewald
Interim Chief Financial Officer
Interim Chief Financial Officer
355.00K
+51.06%
Mr. Mitchell Y. (Mitch) Williams
Mr. Mitchell Y. (Mitch) Williams
Chief Investment Officer
Chief Investment Officer
333.33K
-66.67%
Mr. Karl Henry Mcphie
Mr. Karl Henry Mcphie
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Donald F. Browne, CPA
Mr. Donald F. Browne, CPA
Independent Director
Independent Director
--
--
Mr. Morgan Lekstrom
Mr. Morgan Lekstrom
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kevin Gopaul
Mr. Kevin Gopaul
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ferdinand Groenewald
Mr. Ferdinand Groenewald
Interim Chief Financial Officer
Interim Chief Financial Officer
355.00K
+51.06%
Mr. Mitchell Y. (Mitch) Williams
Mr. Mitchell Y. (Mitch) Williams
Chief Investment Officer
Chief Investment Officer
333.33K
-66.67%
Mr. Karl Henry Mcphie
Mr. Karl Henry Mcphie
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Donald F. Browne, CPA
Mr. Donald F. Browne, CPA
Independent Director
Independent Director
--
--
Mr. Morgan Lekstrom
Mr. Morgan Lekstrom
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kevin Gopaul
Mr. Kevin Gopaul
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 17
Updated: Wed, Dec 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Legacy Wealth Management, LLC
4.98%
Garlikov (Donald E.)
2.01%
Amato (Anthony N.)
2.01%
The Vanguard Group, Inc.
0.89%
Armistice Capital LLC
0.57%
Other
89.55%
Shareholders
Shareholders
Proportion
Legacy Wealth Management, LLC
4.98%
Garlikov (Donald E.)
2.01%
Amato (Anthony N.)
2.01%
The Vanguard Group, Inc.
0.89%
Armistice Capital LLC
0.57%
Other
89.55%
Shareholder Types
Shareholders
Proportion
Investment Advisor
6.56%
Individual Investor
5.03%
Hedge Fund
0.65%
Investment Advisor/Hedge Fund
0.46%
Institution
0.12%
Research Firm
0.08%
Bank and Trust
0.05%
Venture Capital
0.03%
Other
87.03%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
97
10.66M
30.22%
+1.75M
2025Q2
106
19.36M
55.79%
+939.76K
2025Q1
106
15.90M
28.93%
+9.50M
2024Q4
106
9.32M
40.45%
+3.74M
2024Q3
99
5.91M
36.28%
+2.09M
2024Q2
104
3.04M
24.34%
-208.84K
2024Q1
114
2.55M
24.03%
-428.59K
2023Q4
114
2.69M
27.89%
+299.57K
2023Q3
123
1.97M
28.02%
+572.82K
2023Q2
133
1.90M
27.43%
+590.93K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Legacy Wealth Management, LLC
6.84M
19.39%
+622.17K
+10.01%
Jun 30, 2025
Garlikov (Donald E.)
3.04M
8.6%
+730.62K
+31.71%
Jul 22, 2025
Amato (Anthony N.)
3.03M
8.6%
+1.06M
+53.96%
Jul 22, 2025
The Vanguard Group, Inc.
990.15K
2.81%
+930.89K
+1570.77%
Jun 30, 2025
Armistice Capital LLC
854.95K
2.42%
+854.95K
--
Sep 30, 2024
Hrkac (Frederick)
612.85K
1.74%
-41.66K
-6.36%
Apr 24, 2025
Groenewald (Ferdinand)
235.00K
0.67%
--
--
Jul 22, 2025
Browne (Donald F.)
103.34K
0.29%
--
--
Jul 22, 2025
Cambridge Investment Research Advisors, Inc.
134.10K
0.38%
-132.34K
-49.67%
Jun 30, 2025
Rossby Financial, LCC
326.63K
0.93%
-124.50K
-27.60%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jan 31, 2024
Merger
10→1
Jan 31, 2024
Merger
10→1
Jan 31, 2024
Merger
10→1
Jan 31, 2024
Merger
10→1
Date
Type
Ratio
Jan 31, 2024
Merger
10→1
Jan 31, 2024
Merger
10→1
Jan 31, 2024
Merger
10→1
Jan 31, 2024
Merger
10→1
FAQs
Who are the top five shareholders of BioSig Technologies Inc?
The top five shareholders of BioSig Technologies Inc are:
Legacy Wealth Management, LLC holds 6.84M shares, accounting for 19.39% of the total shares.
Garlikov (Donald E.) holds 3.04M shares, accounting for 8.60% of the total shares.
Amato (Anthony N.) holds 3.03M shares, accounting for 8.60% of the total shares.
The Vanguard Group, Inc. holds 990.15K shares, accounting for 2.81% of the total shares.
Armistice Capital LLC holds 854.95K shares, accounting for 2.42% of the total shares.
Legacy Wealth Management, LLC holds 6.84M shares, accounting for 19.39% of the total shares.
Garlikov (Donald E.) holds 3.04M shares, accounting for 8.60% of the total shares.
Amato (Anthony N.) holds 3.03M shares, accounting for 8.60% of the total shares.
The Vanguard Group, Inc. holds 990.15K shares, accounting for 2.81% of the total shares.
Armistice Capital LLC holds 854.95K shares, accounting for 2.42% of the total shares.
What are the top three shareholder types of BioSig Technologies Inc?
The top three shareholder types of BioSig Technologies Inc are:
Legacy Wealth Management, LLC
Garlikov (Donald E.)
Amato (Anthony N.)
Legacy Wealth Management, LLC
Garlikov (Donald E.)
Amato (Anthony N.)
How many institutions hold shares of BioSig Technologies Inc (BSGM)?
As of 2025Q3, 97 institutions hold shares of BioSig Technologies Inc, with a combined market value of approximately 10.66M, accounting for 30.22% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -25.56%.
What is the biggest source of revenue for BioSig Technologies Inc?
In --, the -- business generated the highest revenue for BioSig Technologies Inc, amounting to -- and accounting for --% of total revenue.
